First-Line Treatment for Hemiplegic Migraines
NSAIDs (such as acetylsalicylic acid, ibuprofen, or diclofenac potassium) are the first-line treatment for hemiplegic migraines. 1
Understanding Hemiplegic Migraine
Hemiplegic migraine is a rare subtype of migraine with aura characterized by temporary motor weakness (hemiparesis) during attacks, which may be accompanied by visual, sensory, or speech disturbances. It can occur in two forms:
- Familial hemiplegic migraine (FHM): With autosomal dominant inheritance
- Sporadic hemiplegic migraine (SHM): Without family history
The motor symptoms typically last less than 72 hours and are associated with other aura symptoms 2.
Treatment Algorithm for Hemiplegic Migraines
Acute Treatment
First-line: NSAIDs
For nausea/vomiting
Second-line options (controversial)
Rescue medications
- When other treatments fail, opioids may be considered if risk of abuse has been addressed 1
Important Cautions
- Avoid oral ergot alkaloids, which are poorly effective and potentially toxic 1
- Avoid opioids and barbiturates as regular treatment due to questionable efficacy and risk of dependency 1
- Limit acute treatments to no more than twice weekly to prevent medication overuse headache 1
Preventive Treatment
Consider preventive treatment when:
- Two or more migraine attacks per month with disability for ≥3 days per month
- Use of rescue medication more than twice weekly
- Failure of or contraindications to acute treatments
- Presence of hemiplegic migraine 1
Preventive Options for Hemiplegic Migraine
First-line preventive agents:
- Sodium valproate/divalproex sodium (500-1,500 mg/day)
- Amitriptyline (30-150 mg/day)
- Flunarizine (where available)
- Lamotrigine
- Verapamil
- Acetazolamide 4
Second-line options:
- Topiramate
- Candesartan
- Pizotifen 4
Note on beta-blockers: While propranolol and timolol are first-line for typical migraine, their use in hemiplegic migraine is more controversial, though evidence of adverse effects is insufficient to absolutely contraindicate them 4.
Monitoring and Follow-up
- Evaluate treatment efficacy after 2-3 months for oral preventives 1
- Preventive medications must be given at therapeutic doses for at least 6-8 weeks before judging ineffectiveness 5
- Consider pausing preventive treatment after 6-12 months of successful control 1
Special Considerations
- Patients with hemiplegic migraine may require hospitalization for long-lasting auras 2
- Genetic testing can confirm but not rule out the diagnosis, as some genes remain unidentified 4
- Conventional cerebral angiography is contraindicated in hemiplegic migraine as it may provoke an attack 4
By following this treatment approach, the goal is to reduce the frequency, duration, and severity of hemiplegic migraine attacks while minimizing adverse effects and improving quality of life.